Clinical Trial

SPECT-CT vs MRI for the Diagnosis of Osteoarthritis in the Foot and Ankle

Recruiting
View on ClinicalTrials.gov →
Summary
The diagnose of symptomatic osteoarthritis in the ankle, mid- and hind foot remains challenging. There is no gold standard for the work-up and various hospitals use different protocols. Current literature shows a promising role for SPECT-CT imaging in ankle, hind- and midfoot OA. In a previous study investigating the role of SPECT-CT in a reproducible group we have observed a change in diagnosis in 53% when SPECT-CT data was added to the data of conventional workup alone. In 26% of patients addition of SPECT-CT data resulted in change of the original treatment plan. To our knowledge no prospective studies are available on this subject for both SPECT-CT and MRI. In our clinic both SPECT-CT and MRI are used in the work-up for patients with ankle, hind- and midfoot pain. Although we experience good result with SPECT-CT, MRI might be able to detect symptomatic OA as well. Moreover MRI provide more information about soft tissue and is less harmful for the patient in comparison to SPECT-CT. The aim of this study is to determine the diagnostic performance of SPECT-CT and MRI when used routinely in patients with symptomatic OA of the ankle, hind- and midfoot.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-06-12; most recent amendment 2026-02-24.
Status change: Not Yet Recruiting → Recruiting 2023-07-04
Trial Details
NCT Number NCT05912153
Lead Sponsor Martini Hospital Groningen
Conditions Osteoarthritis Ankle, Osteoarthritis
Enrollment 132 participants
Start Date 2023-07-04
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-27